Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01125150 · ClinicalTrials.gov registry record
Spectroscopic and Colorimetric Analysis of Acanthosis Nigricans in Patients With Hyperinsulinemia
A clinical trial of Hyperinsulinemia and Acanthosis Nigricans, sponsored by Henry Ford Health System.
- Completed
- Registry status
- 9
- Enrollment target
- 1
- Study location
NCT01125150: Completed study of Hyperinsulinemia and Acanthosis Nigricans, sponsored by Henry Ford Health System.
NCT01125150 is a study of Hyperinsulinemia and Acanthosis Nigricans that has completed, run by Henry Ford Health System. The registered enrollment target is 9 participants, below the 254-participant average among 5 other Hyperinsulinemia trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01125150, a study of Hyperinsulinemia and Acanthosis Nigricans, has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- 9 participants
- Enrollment target
- 1
- Study location
Study Summary
Acanthosis Nigricans is skin disease that associated with hyperinsulinemia. Clinical is velvety hyperpigmented plaques on neck, axilla, groin. If hyperinsulinemia is improved by treated with oral metformin and/ or diet control, acanthosis nigricans would be improved as well. Hyperpigmented plaques will be changed. We assess objective measurement by using spectroscopic and colorimetric analysis.
Conditions Studied
Interventions
- DRUG Metformin
- BEHAVIORAL Dietary Modification
Study Locations (1)
Michigan
- Department of Dermatology, NEW CENTER ONE - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2009-02 |
| Est. Completion | 2012-06 |
What the finished NCT01125150 record still lists
NCT01125150 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 254-participant average among 5 other Hyperinsulinemia trials with a reported enrollment target (96% lower).
The record links to 3 conditions, with Hyperinsulinemia appearing as the primary indexed condition, and to 2 interventions - of which Metformin is the first listed.
NCT01125150 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT01125150 about?
NCT01125150 is a clinical study titled "Spectroscopic and Colorimetric Analysis of Acanthosis Nigricans in Patients With Hyperinsulinemia". Acanthosis Nigricans is skin disease that associated with hyperinsulinemia. Clinical is velvety hyperpigmented plaques on neck, axilla, groin. If hyperinsulinemia is improved by treated with oral metformin and/ or diet control, acanthosis nigricans would be improved as well. Hyperpigmented plaques w...
What is the current status of trial NCT01125150?
This trial is currently completed. The enrollment target is 9 participants. The study started on 2009-02. Estimated completion is 2012-06.
What conditions does trial NCT01125150 study?
This clinical trial studies the following conditions: Hyperinsulinemia, Acanthosis Nigricans, Spectroscopic Analysis.
What interventions are being tested in trial NCT01125150?
The interventions under investigation include: Metformin (DRUG), Dietary Modification (BEHAVIORAL).
Who is sponsoring clinical trial NCT01125150?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01125150 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hyperinsulinemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Graded Insulin Suppression Test P&F
RECRUITING · Phase 1
-
Diazoxide Suppression Test P&F Study
RECRUITING · Phase 1
-
The Movie Theater Study
RECRUITING · NA
-
Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks
RECRUITING
-
Reprometabolic Syndrome Mediates Subfertility in Obesity
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia